| Dr Dick L Robbins, MD | |
|
451 E. Health Sciences Drive, Ucdavis School Of Medicine, Davis, CA 95616 | |
| (530) 752-3903 | |
| (530) 754-6047 |
| Full Name | Dr Dick L Robbins |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 451 E. Health Sciences Drive, Davis, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972586352 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | G19508 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dick L Robbins, MD 451 E. Health Sciences Drive, Ucdavis School Of Medicine, Davis, CA 95616 Ph: (530) 752-3903 | Dr Dick L Robbins, MD 451 E. Health Sciences Drive, Ucdavis School Of Medicine, Davis, CA 95616 Ph: (530) 752-3903 |
News Archive
Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo
Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced the acquisition of worldwide rights to a biogeneric version of filgrastim and an affiliated European manufacturing facility from PLIVA Hrvatska d.o.o. (Zagreb, Croatia) (ZSE: PLVA-R-A), a move that will help extend Hospira's reach and vertical integration in biogenerics. Financial terms of the agreement were not disclosed.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
Despite evidence that low-cost diarrhea treatments such as lower osmolarity oral rehydration salts (ORS) and zinc supplements could drastically reduce the number of deaths among children, little progress has been made in implementing these life-saving techniques, according to researchers at the Johns Hopkins Bloomberg School of Public Health.
If patients return to Dr. Crystal Bowe soon after taking medication for a sexually transmitted infection, she usually knows the reason: Their partners have re-infected them.
› Verified 6 days ago
David A. Dycaico, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1955 Cowell Blvd, Davis, CA 95616 Phone: 916-757-7100 | |
Dr. Jafar Alsaid, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2009 Baywood Ln, Davis, CA 95618 Phone: 925-997-4483 | |
Daniel J Kennedy, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1637 Westshore St, Davis, CA 95616 Phone: 530-756-3009 | |
Mrs. Elisabeth Abdin, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2030 Sutter Place, Suite 1000, Davis, CA 95616 Phone: 530-750-5904 Fax: 530-750-5905 | |
Lynn Marie Mcalister, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2000 Sutter Pl, Davis, CA 95616 Phone: 530-750-5226 | |
Dr. Stephen A. Mccurdy, MD Rheumatology Medicare: Medicare Enrolled Practice Location: One Shields Ave., Davis, CA 95616 Phone: 530-752-8051 Fax: 530-752-3239 | |
Dr. Michael Xavier Guzman Ii, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2000 Sutter Pl, Davis, CA 95616 Phone: 530-750-5909 |